{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:19:14Z","timestamp":1767892754406,"version":"3.49.0"},"reference-count":147,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3872,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"NIH","award":["NS26994"],"award-info":[{"award-number":["NS26994"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neurosci. Res."],"published-print":{"date-parts":[[2005,4,1]]},"DOI":"10.1002\/jnr.20395","type":"journal-article","created":{"date-parts":[[2005,1,24]],"date-time":"2005-01-24T19:49:10Z","timestamp":1106596150000},"page":"1-17","source":"Crossref","is-referenced-by-count":48,"title":["Antiglycolipid antibodies in Guillain-Barr\u00e9 syndrome and related diseases: Review of clinical features and antibody specificities"],"prefix":"10.1002","volume":"80","author":[{"given":"Toshio","family":"Ariga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,1,24]]},"reference":[{"key":"10.1002\/jnr.20395-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/00007890-199312000-00049","article-title":"Inflammatory polyneuropathy after heart transplantation. Its association with antibodies to asialo-GM1 and sulfatide","volume":"56","author":"Adair","year":"1993","journal-title":"Transplantation"},{"key":"10.1002\/jnr.20395-BIB2|cit2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-5728(01)00426-X","article-title":"Differential immune response to gangliosides in Gullain-Barr\u00e9 syndrome patients from Japan and The Netherlands","volume":"121","author":"Ang","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/IAI.70.3.1202-1208.2002","article-title":"Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barr\u00e9 and Miller Fischer patients","volume":"70","author":"Ang","year":"2002","journal-title":"Infect Immun"},{"key":"10.1002\/jnr.20395-BIB4|cit4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain-Barr\u00e9 syndrome: a true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1002\/jnr.20395-BIB5|cit5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jnr.490380203","article-title":"Identification of Gal(\u03b21-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve","volume":"38","author":"Apostrolski","year":"1994","journal-title":"J Neurosci Res"},{"key":"10.1002\/jnr.20395-BIB6|cit6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/mus.880160603","article-title":"Acute conduction block in vitro following exposure to antiganglioside sera","volume":"16","author":"Arasaki","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1002\/jnr.20395-BIB7|cit7","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0021-9258(19)75864-5","article-title":"Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy","volume":"262","author":"Ariga","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1002\/jnr.20395-BIB8|cit8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jnr.1162","article-title":"Recent studies on roles of antiglycosphingolipids in the pathogenesis of neurological disorders","volume":"65","author":"Ariga","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1002\/jnr.20395-BIB9|cit9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/088307380001500308","article-title":"New concepts of Guillain Barre syndrome","volume":"15","author":"Asbury","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1002\/jnr.20395-BIB10|cit10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/bi00167a032","article-title":"lipopolysaccharides of Campylobacter jejuni serotype O:19; structure of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barr\u00e9 syndrome","volume":"33","author":"Aspinall","year":"1994","journal-title":"Biochemistry"},{"key":"10.1002\/jnr.20395-BIB11|cit11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1097-4598(199901)22:1<108::AID-MUS16>3.0.CO;2-I","article-title":"Immune-mediated peripheral neuropathies and voltage-gated sodium channels","volume":"22","author":"Benatar","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1002\/jnr.20395-BIB12|cit12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF00915419","article-title":"Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies","volume":"7","author":"Bjorkander","year":"1987","journal-title":"J Clin Immunol"},{"key":"10.1002\/jnr.20395-BIB13|cit13","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1128\/IAI.70.9.5008-5018.2002","article-title":"Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barr\u00e9 syndrome","volume":"70","author":"Bowes","year":"2002","journal-title":"Infect Immun"},{"key":"10.1002\/jnr.20395-BIB14|cit14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF00375050","article-title":"The acute paralysis in Guillain-Barr\u00e9 syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid","volume":"421","author":"Brinkmeier","year":"1992","journal-title":"Pflugers Arch"},{"key":"10.1002\/jnr.20395-BIB15|cit15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/ana.410440610","article-title":"Neuromuscular blockade by IgG antibodies from patients with Guillain-Barr\u00e9 syndrome: a macro-patch-clamp study","volume":"44","author":"Buchwald","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB16|cit16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1212\/WNL.56.1.67","article-title":"Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome","volume":"56","author":"Buchwald","year":"2001","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB17|cit17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0003-2697(85)90641-4","article-title":"Procedure for isolation of gangliosides in high yield and purity: simultaneous isolation of neutral glycosphingolipids","volume":"148","author":"Byrne","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1002\/jnr.20395-BIB18|cit18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","article-title":"Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller-Fisher syndrome and Guillain-Barr\u00e9 syndrome: clinical and immunohistochemical studies","volume":"43","author":"Chiba","year":"1993","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB20|cit20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(96)01123-7","article-title":"Ganglioside composition of the human cranial nerves with special reference to phathophysiology of Miller Fisher syndrome","volume":"745","author":"Chiba","year":"1997","journal-title":"Brain Res"},{"key":"10.1002\/jnr.20395-BIB21|cit21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0404.1991.tb04912.x","article-title":"Treatment of myasthenia gravis with high-dose intravenous immunoglobulin","volume":"84","author":"Cosi","year":"1991","journal-title":"Acta Neurorol Scand"},{"key":"10.1002\/jnr.20395-BIB22|cit22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-5793(92)81234-D","article-title":"Ganglio-N-tetraosylceramide (GA1) of bovine and human brain. Molecular characterization and presence in myelin","volume":"301","author":"Dasgupta","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1002\/jnr.20395-BIB23|cit23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s11064-004-6888-7","article-title":"Lack of apparent neurological abnormalities in rabbits sensitized by gangliosides","volume":"29","author":"Dasgupta","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1002\/jnr.20395-BIB24|cit24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-5728(96)00029-X","article-title":"Affinity of anti-GM1 antibodies in Guillain-Barr\u00e9 syndrome patients","volume":"66","author":"Deisenhammer","year":"1996","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB25|cit25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-5728(03)00156-5","article-title":"Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barr\u00e9 syndrome","volume":"139","author":"Dilley","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB26|cit26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/oxfordjournals.jbchem.a123529","article-title":"Molecular parameters of gangliosides in monolayers: comparative evalution of suitable purification procedures","volume":"110","author":"Fidelio","year":"1991","journal-title":"J Biochem (Tokyo)"},{"key":"10.1002\/jnr.20395-BIB27|cit27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00002371-199909000-00008","article-title":"Immunoadsorption in multifocal neuropathy","volume":"32","author":"Finsterer","year":"1999","journal-title":"J Immunother"},{"key":"10.1002\/jnr.20395-BIB28|cit28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1749-6632.1998.tb09686.x","article-title":"The role of anti-glycolipid antibodies in neurological disorders","volume":"845","author":"Fredman","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1002\/jnr.20395-BIB29|cit29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00839972","article-title":"Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope","volume":"240","author":"Fredman","year":"1993","journal-title":"J Neurol"},{"key":"10.1002\/jnr.20395-BIB30|cit30","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/brain\/awf258","article-title":"Localization of major gangliosides in the PNS: implications for immune neuropathies","volume":"125","author":"Gong","year":"2002","journal-title":"Brain"},{"key":"10.1002\/jnr.20395-BIB31|cit31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI6837","article-title":"Monoclonal antibodies raised against Guillain-Barr\u00e9 syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations","volume":"104","author":"Goodyear","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1002\/jnr.20395-BIB32|cit32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF00314652","article-title":"Acute motor neuropathy with antibodies to GM1 ganglioside","volume":"238","author":"Gregson","year":"1991","journal-title":"J Neurol"},{"key":"10.1002\/jnr.20395-BIB33|cit33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","article-title":"Guillain-Barr\u00e9 syndrome in northern China. The spectrum of neurothological changes in clinically defined cases","volume":"118","author":"Griffin","year":"1995","journal-title":"Brain"},{"key":"10.1002\/jnr.20395-BIB34|cit34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0165-5728(01)00390-3","article-title":"Guillain-Barr\u00e9 syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritis","volume":"119","author":"Hadden","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB35|cit35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB36|cit36","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/1531-8249(199906)45:6<758::AID-ANA10>3.0.CO;2-N","article-title":"Anti-GalNAc-GD1a antibody-associated Guillain-Barr\u00e9 syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance","volume":"45","author":"Hao","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB37|cit37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.neuro.21.1.187","article-title":"Human autoimmune neuropathies","volume":"21","author":"Ho","year":"1998","journal-title":"Annu Rev Neurosci"},{"key":"10.1002\/jnr.20395-BIB38|cit38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial of prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1002\/jnr.20395-BIB39|cit39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-510X(03)00123-0","article-title":"Induction of conduction block by Campylobacter jejuni lipopolysaccharides and focal neural insult","volume":"213","author":"Ifergane","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1002\/jnr.20395-BIB40|cit40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0022-510X(91)90126-R","article-title":"Antibodies to sulfated glycolipids in Guillain-Barr\u00e9 syndrome","volume":"105","author":"Ilyas","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1002\/jnr.20395-BIB41|cit41","first-page":"115","article-title":"Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barr\u00e9 syndrome","volume":"109","author":"Ilyas","year":"2001","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1002\/jnr.20395-BIB42|cit42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-5728(96)00059-8","article-title":"Association of anti-GM2 antibodies in Guillain-Barr\u00e9 syndrome with acute cytomegalovirus infection","volume":"68","author":"Irie","year":"1996","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB43|cit43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barr\u00e9 syndrome","volume":"40","author":"Jacobs","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB44|cit44","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jnnp.62.6.641","article-title":"Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barr\u00e9 syndrome","volume":"62","author":"Jacobs","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/jnr.20395-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barre syndrome. A case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB46|cit46","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/brain\/awg235","article-title":"Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding","volume":"126","author":"Jacobs","year":"2003","journal-title":"Brain"},{"key":"10.1002\/jnr.20395-BIB47|cit47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0955-3886(93)90046-W","article-title":"Adsorption therapy with tryptophan-conjugated polyvinyl alcohol gels in 10 patients with acute Guillain-Barr\u00e9 syndrome","volume":"14","author":"Jimenez","year":"1993","journal-title":"Transfus Sci"},{"key":"10.1002\/jnr.20395-BIB48|cit48","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/BF00968704","article-title":"Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system-a review","volume":"19","author":"Jungalwala","year":"1994","journal-title":"Neurochem Res"},{"key":"10.1002\/jnr.20395-BIB49|cit49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/123.1.116","article-title":"Guillain-Barr\u00e9 syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a","volume":"123","author":"Kaida","year":"2000","journal-title":"Brain"},{"key":"10.1002\/jnr.20395-BIB50|cit50","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0165-5728(00)00451-3","article-title":"Guillain-Barre syndrome with IgM antibody to the ganglioside GalNAc-GD1a","volume":"113","author":"Kaida","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB51|cit51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/01.WNL.0000081229.88862.C6","article-title":"GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody","volume":"61","author":"Kaida","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB52|cit52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1083\/jcb.126.1.235","article-title":"Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy","volume":"126","author":"Kanda","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1002\/jnr.20395-BIB53|cit53","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1212\/WNL.55.4.585","article-title":"Anti-GM1 antibody facilitates leakage in an in vitro blood-nerve barrier model","volume":"55","author":"Kanda","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB54|cit54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/01.WNL.0000041494.70178.17","article-title":"Sera from Guillain-Barr\u00e9 patients enhance leakage in blood-nerve barrier model","volume":"60","author":"Kanda","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB55|cit55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","article-title":"Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system","volume":"30","author":"Kieseier","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1002\/jnr.20395-BIB56|cit56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-510X(98)00020-3","article-title":"Guillain-Barr\u00e9 syndrome associated with IgG anti-GM1b antibody subsequent to Mycoplasma pneumoniae infection","volume":"156","author":"Kitazawa","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1002\/jnr.20395-BIB57|cit57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(98)00016-2","article-title":"Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barr\u00e9 syndrome?","volume":"86","author":"Koga","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB58|cit58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0165-5728(99)00040-5","article-title":"Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barr\u00e9 syndrome after Camplybacter jejuni enteritis","volume":"96","author":"Koga","year":"1999a","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB59|cit59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jnnp.66.4.513","article-title":"Antiganglioside antibody in patients with Guillain-Barr\u00e9 syndrome who show bulbar palsy as an initial symptom","volume":"66","author":"Koga","year":"1999b","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/jnr.20395-BIB60|cit60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0022-510X(98)00331-1","article-title":"Antibodies to GD3, GT3, and O-acetylated species in Guillain-Barr\u00e9 and Fisher's syndrome: their association with cranial nerve dysfunction","volume":"64","author":"Koga","year":"1999c","journal-title":"J Neurol Sci"},{"key":"10.1002\/jnr.20395-BIB61|cit61","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1471-4159.1988.tb01823.x","article-title":"Preparation and characterization of antibodies against a sulfated glucuronic acid-containing glycosphingolipid","volume":"51","author":"Kohriyama","year":"1988","journal-title":"J Neurochem"},{"key":"10.1002\/jnr.20395-BIB62|cit62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.410350217","article-title":"The clinical correlates of high-titer IgG anti-GM1 antibodies","volume":"35","author":"Kornberg","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB63|cit63","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00019052-200210000-00009","article-title":"Nerve conduction studies in selected peripheral nerve disorders","volume":"15","author":"Krarup","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1002\/jnr.20395-BIB64|cit64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(85)90573-6","article-title":"Ganglio-N-tetraosylceramide (asialo-GM1), an antigen common to the brain and immune system: its localization in myelin","volume":"334","author":"Kusunoki","year":"1985","journal-title":"Brain Res"},{"key":"10.1002\/jnr.20395-BIB65|cit65","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.410350510","article-title":"N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barr\u00e9 syndrome","volume":"35","author":"Kusunoki","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB66|cit66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/mus.880180407","article-title":"Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection","volume":"18","author":"Kusunoki","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1002\/jnr.20395-BIB67|cit67","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.410390404","article-title":"Experimental sensory neuropathy induced by sensitization with ganglioside GD1b","volume":"39","author":"Kusunoki","year":"1996a","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB68|cit68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1212\/WNL.47.1.237","article-title":"GM1b is a new number of antigen for serum antibody in Guillain-Barr\u00e9 syndrome","volume":"47","author":"Kusunoki","year":"1996b","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB69|cit69","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/(SICI)1097-4598(199707)20:7<840::AID-MUS8>3.0.CO;2-7","article-title":"Binding of antibodies against GM1 and GD1b in human peripheral nerve","volume":"20","author":"Kusunoki","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1002\/jnr.20395-BIB70|cit70","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410440210","article-title":"IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barr\u00e9 syndrome","volume":"44","author":"Kuwabara","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB71|cit71","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.WNL.0000133205.05169.04","article-title":"Does Campylobacter jejuni infection elicit \u201cdemyelination\u201d Guillain-Barr\u00e9 syndrome?","volume":"63","author":"Kuwabara","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB72|cit72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jnnp.61.3.279","article-title":"Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barr\u00e9 syndrome","volume":"61","author":"Li","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/jnr.20395-BIB73|cit73","doi-asserted-by":"crossref","first-page":"11743","DOI":"10.1073\/pnas.90.24.11743","article-title":"IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebella Purkinje cells and in isolated channel protein in lipid bilayer","volume":"90","author":"Llinas","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/jnr.20395-BIB74|cit74","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1023\/A:1020232318647","article-title":"The origin of anti-GM1 antibodies in neuropathies: the \u201cbinding bite drift\u201d hypothesis","volume":"27","author":"Lopez","year":"2002","journal-title":"Neurochem Res"},{"key":"10.1002\/jnr.20395-BIB75|cit75","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0006-8993(91)91026-W","article-title":"Preliminary studies on the sensitization of Lewis rats with sulfated glucuronyl paragloboside","volume":"541","author":"Maeda","year":"1991","journal-title":"Brain Res"},{"key":"10.1002\/jnr.20395-BIB76|cit76","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410390121","article-title":"Intravenous gamma-globulin inhibits binding of anti-GM1 to its target antigen","volume":"39","author":"Malik","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB77|cit77","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.410230406","article-title":"Plasmapheresis and Guillain-Barr\u00e9 syndrome: analysis of prognostic factors and the effect of plasmapheresis","volume":"23","author":"McKhann","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(02)00036-9","article-title":"Sialosyl-galactose: a common denominator of Guillain-Barr\u00e9 and related disorders?","volume":"196","author":"Moran","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1002\/jnr.20395-BIB79|cit79","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1471-4159.1990.tb04172.x","article-title":"Sulfoglucruonyl paragloboside in rat bran microvessels","volume":"55","author":"Miyatani","year":"1990","journal-title":"J Neurochem"},{"key":"10.1002\/jnr.20395-BIB80|cit80","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1388-2457(02)00108-6","article-title":"Effect of amyotrophic lateral sclerosis serum on calcium channels related to spontaneous acetylcholine release","volume":"113","author":"Muchnik","year":"2002","journal-title":"Clin Neurophysiol"},{"key":"10.1002\/jnr.20395-BIB81|cit81","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1128\/IAI.70.9.5299-5303.2002","article-title":"Campylobacter jejuni from patients with Guillain-Barr\u00e9 syndrome preferentially expresses an GD(1a)-like epitope","volume":"70","author":"Nachamkin","year":"2002","journal-title":"Infect Immun"},{"key":"10.1002\/jnr.20395-BIB82|cit82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-3940(76)90033-1","article-title":"Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides","volume":"2","author":"Nagai","year":"1976","journal-title":"Neurosci Lett"},{"key":"10.1002\/jnr.20395-BIB83|cit83","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1600-0404.1999.tb00387.x","article-title":"Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients","volume":"100","author":"Niebroj-Dobosz","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1002\/jnr.20395-BIB84|cit84","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-510X(96)00106-2","article-title":"Post-infections encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection","volume":"140","author":"Nishmura","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1002\/jnr.20395-BIB85|cit85","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(01)00266-1","article-title":"Multifocal motor neuropathy","volume":"115","author":"Nobile-Ozazio","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1212\/WNL.40.11.1747","article-title":"Anti-GM1 IgM antibodies in motor neuron disease and neuropathy","volume":"40","author":"Nobile-Orazio","year":"1990","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB87|cit87","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0022-510X(92)90169-L","article-title":"Guillain-Barr\u00e9 syndrome associated with high titers of anti-GM1 antibodies","volume":"109","author":"Nobile-Ozazio","year":"1992","journal-title":"J Neurol Sci"},{"key":"10.1002\/jnr.20395-BIB88|cit88","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp.70.1.50","article-title":"Anti-GQ1b IgG antibody syndrome: clinical and immunological range","volume":"70","author":"Odaka","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/jnr.20395-BIB89|cit89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-5728(94)90146-5","article-title":"Antibodies against sulfated glycosphingolipids of peripheral nerve myelin detected in patients with human cytomegalovirus infection","volume":"55","author":"Ogawa-Goto","year":"1994","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB90|cit90","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","article-title":"Axonal Guillain-Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan","volume":"48","author":"Ogawara","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB91|cit91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00005072-199602000-00007","article-title":"Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system","volume":"55","author":"O'Hanlon","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1002\/jnr.20395-BIB92|cit92","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/brain\/124.5.893","article-title":"Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal","volume":"124","author":"O'Hanlon","year":"2001","journal-title":"Brain"},{"key":"10.1002\/jnr.20395-BIB93|cit93","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-5728(01)00373-3","article-title":"IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release","volume":"119","author":"Ortiz","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB94|cit94","first-page":"341","article-title":"Lipopolysaccharides in the development of the Guillain-Barr\u00e9 syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies","volume":"6","author":"Prendergast","year":"2000","journal-title":"J Endotoxin Res"},{"key":"10.1002\/jnr.20395-BIB95|cit95","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0165-5728(99)00199-X","article-title":"Use of peptide ligands to analyze the fine specificity of antibodies against asialo GM1","volume":"100","author":"Qiu","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB96|cit96","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-5728(00)00452-5","article-title":"Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells","volume":"114","author":"Quattrini","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/(SICI)1097-4598(199810)21:10<1327::AID-MUS14>3.0.CO;2-Z","article-title":"Relapses in the Guillain-Barr\u00e9 syndrome after treatment with intravenous immune globulin or plasma exchange","volume":"21","author":"Romano","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1002\/jnr.20395-BIB98|cit98","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0165-5728(97)00213-0","article-title":"Gangliosides do not elicit experimental autoimmune encephalomyelitis in Lewis rats and SJL mice","volume":"84","author":"Saez-Torres","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1126\/science.451555","article-title":"Experimental allergic neuritis induced by sensitization with galactocerebroside","volume":"204","author":"Saida","year":"1979","journal-title":"Science"},{"key":"10.1002\/jnr.20395-BIB100|cit100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0140-6736(80)90076-8","article-title":"Anti-asialo-GM1 antibody in sera from patients with Graves' disease and Hashimoto's thyroditis","volume":"2","author":"Sawada","year":"1980","journal-title":"Lancet"},{"key":"10.1002\/jnr.20395-BIB101|cit101","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/(SICI)1097-0029(19960801)34:5<452::AID-JEMT5>3.0.CO;2-O","article-title":"Molecular specializations at nodes and paranodes in peripheral nerve","volume":"34","author":"Scherer","year":"1996","journal-title":"Microsc Res Techniq"},{"key":"10.1002\/jnr.20395-BIB102|cit102","first-page":"350","article-title":"Penner's serotype 19 Campylobacter jejuni lipopolysaccharide isolated from a patient with acute motor axonal neuropathy bears L2\/HNK1 and GM1 epitopes","volume":"38","author":"Sheikh","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB103|cit103","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/brain\/122.3.449","article-title":"The distribution of ganglioside-like moieties in peripheral nerves","volume":"122","author":"Sheikh","year":"1999","journal-title":"Brain"},{"key":"10.1002\/jnr.20395-BIB104|cit104","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ana.20173","article-title":"An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice","volume":"56","author":"Sheikh","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1046\/j.1471-4159.2002.01247.x","article-title":"Identification of a peptide mimic of the L2\/HNK-1 carbohydrate epitope","volume":"83","author":"Simon-Haldi","year":"2002","journal-title":"J Neurochem"},{"key":"10.1002\/jnr.20395-BIB106|cit106","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-5728(00)00417-3","article-title":"Features of sensory ataxic neuropathy associated with anti-GD1b IgM antibody","volume":"112","author":"Suzuki","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB107|cit107","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-510X(02)00005-9","article-title":"Fine specificities of anti-LM1 IgG antibodies in Guillain-Barr\u00e9 syndrome","volume":"195","author":"Suzuki","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1002\/jnr.20395-BIB108|cit108","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.33333","article-title":"Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons","volume":"54","author":"Suzuki","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB109|cit109","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-2275(20)40231-7","article-title":"The nomenclature of gangliosides","volume":"5","author":"Svennerholm","year":"1964","journal-title":"J Lipid Res"},{"key":"10.1002\/jnr.20395-BIB110|cit110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0165-5728(97)00005-2","article-title":"Cholinergic neuron-specific ganglioside GQ1b-alpha a possible target molecule for serum IgM antibodies in some patients with sensory ataxia","volume":"75","author":"Tagawa","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB111|cit111","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1023\/B:NERE.0000021239.86287.a3","article-title":"Effect of rabbit anti-asialo-GM1 (GA1) polyclonal antibodies on neuromuscular transmission and acetylcholine-induced action potentials; neurophysiological and immunohistochemical studies","volume":"29","author":"Taguchi","year":"2004a","journal-title":"Neurochem Res"},{"key":"10.1002\/jnr.20395-BIB112|cit112","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jns.2004.07.011","article-title":"Neurophysiological and immunobiological studies on Guillain-Barr\u00e9 syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission","volume":"225","author":"Taguchi","year":"2004b","journal-title":"J Neurol Sci"},{"key":"10.1002\/jnr.20395-BIB113|cit113","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ana.410370405","article-title":"Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers","volume":"37","author":"Takigawa","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB114|cit114","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2169\/internalmedicine.39.123","article-title":"The sera from GM1 ganglioside antibody positive patients with Guillain-Barr\u00e9 syndrome or chronic inflammatory demyelinating polyneuropathy blocks Na+ currents in rat single myelinated nerve fibers","volume":"39","author":"Takigawa","year":"2000","journal-title":"Intern Med"},{"key":"10.1002\/jnr.20395-BIB115|cit115","first-page":"43","article-title":"Intravenous immune globulin in the Guillain-Barr\u00e9 syndrome","volume":"97","author":"van der Meche","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1002\/jnr.20395-BIB116|cit116","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome","volume":"326","author":"van der Meche","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1002\/jnr.20395-BIB117|cit117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1212\/WNL.40.2.209","article-title":"High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study","volume":"40","author":"van Doorn","year":"1990","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB118|cit118","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1212\/WNL.47.3.668","article-title":"Cytomegalovirus infection and Guillain-Barr\u00e9 syndrome: the clinical electrophisiologic, and prognostic features","volume":"47","author":"Visser","year":"1996","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB119|cit119","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1086\/513787","article-title":"Insights into Campylobacter jejuni-induced Guillain-Barr\u00e9 syndrome from the Lewis rat model of experimental allergic neuritis","volume":"176","author":"Vriesendorp","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1002\/jnr.20395-BIB120|cit120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.410340206","article-title":"Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barr\u00e9 syndrome and controls: correlation and prognosis","volume":"34","author":"Vriesendorp","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB121|cit121","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s004150050490","article-title":"A small sodium channel blocking factor in the cerebrospinal fluid is preferentially found in Guillain-Barr\u00e9 syndrome: a combined cell physiological and HPLC study","volume":"246","author":"Weber","year":"1999","journal-title":"J Neurol"},{"key":"10.1002\/jnr.20395-BIB122|cit122","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/1097-4598(200009)23:9<1414::AID-MUS13>3.0.CO;2-0","article-title":"Anti-GM1 antibodies can block neuronal voltage-gated sodium channels","volume":"23","author":"Weber","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1002\/jnr.20395-BIB123|cit123","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.4049\/jimmunol.149.7.2518","article-title":"Structure and specificities of anti-ganglioside autoantibodies associated with motor neuropathies","volume":"149","author":"Weng","year":"1992","journal-title":"J Immunol"},{"key":"10.1002\/jnr.20395-BIB124|cit124","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/brain\/124.5.893","article-title":"Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of motor nerve terminal","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"key":"10.1002\/jnr.20395-BIB125|cit125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-5728(93)90239-U","article-title":"Gangliosides and bacterial toxins in Guillain-Barr\u00e9 syndrome","volume":"46","author":"Willison","year":"1993","journal-title":"J Neuroimmuol"},{"key":"10.1002\/jnr.20395-BIB126|cit126","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1002\/jnr.20395-BIB127|cit127","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/brain\/awh083","article-title":"Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmunue neuropathy sera","volume":"127","author":"Willison","year":"2004","journal-title":"Brain"},{"key":"10.1002\/jnr.20395-BIB128|cit128","first-page":"451","article-title":"Filtration of cerebrospinal fluid in acute inflammatory demyelinating polyneuropathy (Guillain-Barr\u00e9 syndrome)","volume":"145","author":"Wollinsky","year":"1994","journal-title":"Ann Med Intern"},{"key":"10.1002\/jnr.20395-BIB129|cit129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1097-4547(19960401)44:1<58::AID-JNR8>3.0.CO;2-H","article-title":"Sensitization of Lewis rats with sulfoglucuronosyl paragloboside: electrophysiological and immunological studies of an animal model of peripheral neuropathy","volume":"44","author":"Yamawaki","year":"1996","journal-title":"J Neurosci Res"},{"key":"10.1002\/jnr.20395-BIB130|cit130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000116872","article-title":"IgG antibody against GM1, GD1b and asialo-GM1 in chronic polyneuropathy following Mycoplasma pneumoniae infection","volume":"32","author":"Yoshino","year":"1992","journal-title":"Eur Neurol"},{"key":"10.1002\/jnr.20395-BIB131|cit131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-5728(99)00280-5","article-title":"IgG anti-ganglioside antibodies in Guillain-Barr\u00e9 syndrome with bulbar palsy","volume":"105","author":"Yoshino","year":"2000","journal-title":"J Neuroimminol"},{"key":"10.1002\/jnr.20395-BIB132|cit132","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1749-6632.1998.tb09682.x","article-title":"The role of glycosphingolipids in neurological disorders. Mechanisms of immune action","volume":"845","author":"Yu","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1002\/jnr.20395-BIB133|cit133","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/ana.410270709","article-title":"Autoimmune mechanisms in peripheral neuropathies","volume":"27","author":"Yu","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB134|cit134","first-page":"1472","article-title":"Analysis of serum anti-GM1 antibody titer in patients receiving GM1 therapy","volume":"18","author":"Yu","year":"1992","journal-title":"Soc Neurosci Abstr"},{"key":"10.1002\/jnr.20395-BIB135|cit135","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1212\/WNL.46.6.1644","article-title":"Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome. A new approach to treatment","volume":"46","author":"Yuki","year":"1996","journal-title":"Neurology"},{"key":"10.1002\/jnr.20395-BIB136|cit136","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1086\/513800","article-title":"Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barr\u00e9 syndrome and Miller Fisher syndrome","volume":"176","author":"Yuki","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1002\/jnr.20395-BIB137|cit137","first-page":"3","article-title":"Anti-ganglioside antibody and neuropathy: review of our research","volume":"3","author":"Yuki","year":"1998","journal-title":"J Periph Nerv Syst"},{"key":"10.1002\/jnr.20395-BIB138|cit138","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-510X(97)05392-6","article-title":"Antibodies to fucogangliosides in neurological diseases","volume":"15","author":"Yuki","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1002\/jnr.20395-BIB139|cit139","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1084\/jem.178.5.1771","article-title":"A bacterium lipopolysaccharide that elicits Guillain-Barr\u00e9 syndrome has a GM1 ganglioside-like structure","volume":"178","author":"Yuki","year":"1993","journal-title":"J Exp Med"},{"key":"10.1002\/jnr.20395-BIB140|cit140","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ana.410360517","article-title":"Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome","volume":"36","author":"Yuki","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB141|cit141","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(96)00142-7","article-title":"Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barr\u00e9 syndrome subsequent to Campylobacter jejuni enteritis","volume":"71","author":"Yuki","year":"1996a","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB142|cit142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(96)00042-2","article-title":"Antibodies to peripheral nerve glycolipids SPG, SLPG and SGPG in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polynruropathies","volume":"70","author":"Yuki","year":"1996b","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB143|cit143","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-5728(96)00201-9","article-title":"Close association of Guillain-Barr\u00e9 syndrome with to minor monosialogangliosides GM1b and GM1alpha","volume":"74","author":"Yuki","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1002\/jnr.20395-BIB144|cit144","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(99)00056-8","article-title":"Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China","volume":"164","author":"Yuki","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1002\/jnr.20395-BIB145|cit145","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/1531-8249(200003)47:3<314::AID-ANA6>3.0.CO;2-C","article-title":"Clinical futures and response to treatment in Guillain-Barr\u00e9 syndrome associated with antibodies to GM1b ganglioside","volume":"47","author":"Yuki","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB146|cit146","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","article-title":"Animal model of axonal Guillain-Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside","volume":"49","author":"Yuki","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1002\/jnr.20395-BIB147|cit147","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipo-oligosaccharide causes Guillain-Barr\u00e9 syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjnr.20395","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jnr.20395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T19:34:49Z","timestamp":1682969689000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jnr.20395"}},"subtitle":["Antiglycolipid Antibodies in Guillain-Barr\u00e9 Syndrome"],"short-title":[],"issued":{"date-parts":[[2005,1,24]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jnr.20395","archive":["Portico"],"relation":{},"ISSN":["0360-4012"],"issn-type":[{"value":"0360-4012","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1,24]]}}}